首页 > 最新文献

Journal of Research in Medical Sciences最新文献

英文 中文
Success rate and complications of performing elective ureteroscopy in <1 week versus over 1 week from renal colic initiation in ureteral stones larger than 6 mm. 对于大于 6 毫米的输尿管结石,在肾绞痛开始后 1 周内与 1 周以上进行择期输尿管镜检查的成功率和并发症。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-11 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_43_23
Reza Kazemi, Amir Javid, Amir Hossein Ghandehari, Hanieh Salehi

Background: The aim of this study was to compare the outcomes, success rate, and complications of performing elective ureteroscopy at different times: <1 week from renal colic initiation (early) and more than 1 week from renal colic initiation (late) in patients with ureteral stone larger than 6 mm.

Materials and methods: This comparative observational study was conducted on 338 consecutive patients. Patients were evaluated in two groups: patients who underwent ureteroscopy in <1 week (A) and patients who underwent ureteroscopy in more than 1 week (B) from renal colic initiation. Helical unenhanced computed tomography was used to assess the size, location, and hardness of stone for all patients. Operation success was defined as complete clearance of stone with no stone residue (stone free) at 2-week postoperative ultrasonography with no need to further interventions. Operation data were collected using medical records, and postoperative complications were investigated at 2 weeks postoperative follow-up visits.

Results: Group A included 165 patients and Group B included 173 patients. The overall mean stone size was 8.60 ± 1.12 mm: for Group A 9.13 ± 0.94 mm and for Group B 8.10 ± 1.04 mm (P < 0.001). Stone residues were found in 11 patients: 9 in Group A (5.4%) and 2 in Group B (1.1%) (P = 0.026). Nine patients needed repeated ureteroscopy: 8 (4.8%) in Group A and 1 (0.6%) in Group B (P = 0.015). A double-J stent was used for 85 (51.5%) patients in Group A and 66 (38.2%) patients in Group B (P = 0.016). Major intraoperative complications did not happen in any patients. Fifty-three (32.1%) patients in Group A and 28 (16.2%) patients in Group B suffered from postoperative complications (P = 0.001).

Conclusion: Our study revealed that performing elective ureteroscopy with an interval of more than 1 week from the onset of renal colic in combination with medical treatments was associated with less need for double-J stent placement, less need for repeated ureteroscopy, and fewer postoperative complications compared to performing elective ureteroscopy in <1 week from the renal colic onset in nonemergent patients with ureteral stone larger than 6 mm. Although the rate of ureteroscopy failure was higher among the patients who underwent ureteroscopy in <1 week from their renal colic initiation, there was no statistically significant relationship between performing ureteroscopy in <1 week and an increased risk for ureteroscopy failure.

研究背景本研究旨在比较在不同时间进行择期输尿管镜检查的结果、成功率和并发症:材料和方法:这项比较观察研究对 338 名连续患者进行了评估。患者分为两组进行评估:A 组包括 165 名患者,B 组包括 165 名患者:A 组包括 165 名患者,B 组包括 173 名患者。结石总平均大小为 8.60 ± 1.12 毫米:A 组为 9.13 ± 0.94 毫米,B 组为 8.10 ± 1.04 毫米(P < 0.001)。11 名患者发现结石残留:A 组 9 人(5.4%),B 组 2 人(1.1%)(P = 0.026)。九名患者需要再次接受输尿管镜检查:A 组 8 人(4.8%),B 组 1 人(0.6%)(P = 0.015)。A 组有 85 人(51.5%)使用了双 J 支架,B 组有 66 人(38.2%)使用了双 J 支架(P = 0.016)。所有患者均未发生重大术中并发症。A组53例(32.1%)和B组28例(16.2%)患者出现术后并发症(P = 0.001):我们的研究表明,在肾绞痛发生后间隔 1 周以上再进行选择性输尿管镜检查并结合药物治疗,与在肾绞痛发生后间隔 1 周以上再进行选择性输尿管镜检查并结合药物治疗相比,更不需要放置双 J 支架,更不需要重复进行输尿管镜检查,术后并发症也更少。
{"title":"Success rate and complications of performing elective ureteroscopy in <1 week versus over 1 week from renal colic initiation in ureteral stones larger than 6 mm.","authors":"Reza Kazemi, Amir Javid, Amir Hossein Ghandehari, Hanieh Salehi","doi":"10.4103/jrms.jrms_43_23","DOIUrl":"10.4103/jrms.jrms_43_23","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to compare the outcomes, success rate, and complications of performing elective ureteroscopy at different times: <1 week from renal colic initiation (early) and more than 1 week from renal colic initiation (late) in patients with ureteral stone larger than 6 mm.</p><p><strong>Materials and methods: </strong>This comparative observational study was conducted on 338 consecutive patients. Patients were evaluated in two groups: patients who underwent ureteroscopy in <1 week (A) and patients who underwent ureteroscopy in more than 1 week (B) from renal colic initiation. Helical unenhanced computed tomography was used to assess the size, location, and hardness of stone for all patients. Operation success was defined as complete clearance of stone with no stone residue (stone free) at 2-week postoperative ultrasonography with no need to further interventions. Operation data were collected using medical records, and postoperative complications were investigated at 2 weeks postoperative follow-up visits.</p><p><strong>Results: </strong>Group A included 165 patients and Group B included 173 patients. The overall mean stone size was 8.60 ± 1.12 mm: for Group A 9.13 ± 0.94 mm and for Group B 8.10 ± 1.04 mm (<i>P</i> < 0.001). Stone residues were found in 11 patients: 9 in Group A (5.4%) and 2 in Group B (1.1%) (<i>P</i> = 0.026). Nine patients needed repeated ureteroscopy: 8 (4.8%) in Group A and 1 (0.6%) in Group B (<i>P</i> = 0.015). A double-J stent was used for 85 (51.5%) patients in Group A and 66 (38.2%) patients in Group B (<i>P</i> = 0.016). Major intraoperative complications did not happen in any patients. Fifty-three (32.1%) patients in Group A and 28 (16.2%) patients in Group B suffered from postoperative complications (<i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>Our study revealed that performing elective ureteroscopy with an interval of more than 1 week from the onset of renal colic in combination with medical treatments was associated with less need for double-J stent placement, less need for repeated ureteroscopy, and fewer postoperative complications compared to performing elective ureteroscopy in <1 week from the renal colic onset in nonemergent patients with ureteral stone larger than 6 mm. Although the rate of ureteroscopy failure was higher among the patients who underwent ureteroscopy in <1 week from their renal colic initiation, there was no statistically significant relationship between performing ureteroscopy in <1 week and an increased risk for ureteroscopy failure.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"27"},"PeriodicalIF":1.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome. 制定第一份伊朗急性冠状动脉综合征诊断、治疗和二级预防临床实践指南。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-11 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_851_23
Nizal Sarrafzadegan, Fahimeh Bagherikholenjani, Shahla Shahidi, Golsa Ghasemi, Ehsan Shirvani, Fatemeh Rajati, Farid Najafi, Samad Ghaffari, Alireza Khosravi, Ahmadreza Assareh, Seyed Mohammad Hassan Adel, Javad Kojuri, Niloufar Samiei, Farzad Masoudkabir, Hossein Farshidi, Mohammad Kermani-Alghoraishi, Masoumeh Sadeghi, Davood Shafei, Masoumeh Jorjani, Mansour Siavash, Fariborz Khorvash, Mehdi Nasr Isfahani, Behzad Fatemi, Majid Davari, Mitra Moradinia, Ramesh Hoseinkhani, Valiollah Hajhashemi, Noushin Mohammadifard, Majid Ghayour Mobarhan, Ali Momeni, Mojgan Mortazavi, Mohammad Akbari, Fereshteh Sattar, Fereidoun Noohi, Maryam Kheiri, Mosa Tabatabaeilotfi, Sanaz Bakhshandeh, Parisa Janjani, Sajad Fakhri, Alireza Abdi

Background: This article introduces the first national guidelines for the management including diagnosis, treatment, and secondary prevention of acute coronary syndrome (ACS) in Iran.

Materials and methods: The members of the guideline development group (GDG) were specialists and experts in fields related to ACS and were affiliated with universities of medical sciences or scientific associations in the country. They carefully examined the evidence and clinical concerns related to ACS management and formulated 13 clinical questions that were sent to systematic review group who developed related evidence using Grade method. Finally the GDG developed the recommendations and suggestions of the guideline.

Results: The first three questions in the guideline focus on providing recommendations for handling a patient who experience chest pain at home, in a health house or center, during ambulance transportation, and upon arrival at the emergency department (ED) as well as the initial diagnostic measures in the ED. Subsequently, the recommendations related to the criteria for categorizing patients into low, intermediate and high-risk groups are presented. The guideline addressed primary treatment measures for ACS patients in hospitals with and without code 247 or having primary percutaneous coronary intervention (PCI) facilities, and the appropriate timing for PCI based on the risk assessment. In addition, the most efficacious antiplatelet medications for ACS patients in the ED as well as its optimal duration of treatment are presented. The guideline details the recommendations for therapeutic interventions in patients with ACS and acute heart failure, cardiogenic shock, myocardial infarction with nonobstructive coronary arteries (MINOCA), multivessel occlusion, as well as the indication for prescribing a combined use of anticoagulants and antiplatelet during hospitalization and upon discharge. Regarding secondary prevention, while emphasizing the referral of these patients to rehabilitation centers, other interventions that include pharmaceutical and nonpharmacological ones are addressed, In addition, necessary recommendations for enhancing lifestyle and posthospital discharge pharmaceutical treatments, including their duration, are provided. There are specific recommendations and suggestions for subgroups, such as patients aged over 75 years and individuals with heart failure, diabetes, and chronic kidney disease.

Conclusion: Developing guidelines for ACS diagnosis, treatment and secondary prevention according to the local context in Iran can improve the adherence of our health care providers, patients health, and policy makers plans.

背景:本文介绍了伊朗第一份急性冠状动脉综合征(ACS)的管理指南,包括诊断、治疗和二级预防:指南制定小组(GDG)的成员均为 ACS 相关领域的专家,隶属于国内的医科大学或科学协会。他们仔细研究了与 ACS 管理相关的证据和临床问题,提出了 13 个临床问题,并将这些问题提交给系统综述小组,该小组采用分级法开发了相关证据。最后,GDG 提出了指南的建议和意见:指南中的前三个问题主要针对在家中、卫生所或中心、救护车运送途中、到达急诊科(ED)后处理胸痛患者的建议,以及急诊科的初步诊断措施。随后,介绍了将患者分为低危、中危和高危组标准的相关建议。该指南探讨了在有代码 247 或无代码 247 或有初级经皮冠状动脉介入治疗(PCI)设施的医院中对 ACS 患者采取的初级治疗措施,以及根据风险评估确定 PCI 的适当时机。此外,还介绍了急诊室 ACS 患者最有效的抗血小板药物及其最佳治疗时间。该指南详细介绍了 ACS 和急性心力衰竭、心源性休克、冠状动脉非阻塞性心肌梗死(MINOCA)、多支血管闭塞患者的治疗干预建议,以及住院期间和出院后联合使用抗凝剂和抗血小板的适应症。在二级预防方面,在强调将这些患者转诊至康复中心的同时,还讨论了包括药物和非药物在内的其他干预措施,此外,还提供了关于加强生活方式和出院后药物治疗(包括持续时间)的必要建议。针对 75 岁以上患者、心力衰竭患者、糖尿病患者和慢性肾病患者等亚群提出了具体的建议和意见:结论:根据伊朗当地的实际情况制定 ACS 诊断、治疗和二级预防指南,可以提高医疗服务提供者、患者健康和政策制定者的依从性。
{"title":"Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome.","authors":"Nizal Sarrafzadegan, Fahimeh Bagherikholenjani, Shahla Shahidi, Golsa Ghasemi, Ehsan Shirvani, Fatemeh Rajati, Farid Najafi, Samad Ghaffari, Alireza Khosravi, Ahmadreza Assareh, Seyed Mohammad Hassan Adel, Javad Kojuri, Niloufar Samiei, Farzad Masoudkabir, Hossein Farshidi, Mohammad Kermani-Alghoraishi, Masoumeh Sadeghi, Davood Shafei, Masoumeh Jorjani, Mansour Siavash, Fariborz Khorvash, Mehdi Nasr Isfahani, Behzad Fatemi, Majid Davari, Mitra Moradinia, Ramesh Hoseinkhani, Valiollah Hajhashemi, Noushin Mohammadifard, Majid Ghayour Mobarhan, Ali Momeni, Mojgan Mortazavi, Mohammad Akbari, Fereshteh Sattar, Fereidoun Noohi, Maryam Kheiri, Mosa Tabatabaeilotfi, Sanaz Bakhshandeh, Parisa Janjani, Sajad Fakhri, Alireza Abdi","doi":"10.4103/jrms.jrms_851_23","DOIUrl":"10.4103/jrms.jrms_851_23","url":null,"abstract":"<p><strong>Background: </strong>This article introduces the first national guidelines for the management including diagnosis, treatment, and secondary prevention of acute coronary syndrome (ACS) in Iran.</p><p><strong>Materials and methods: </strong>The members of the guideline development group (GDG) were specialists and experts in fields related to ACS and were affiliated with universities of medical sciences or scientific associations in the country. They carefully examined the evidence and clinical concerns related to ACS management and formulated 13 clinical questions that were sent to systematic review group who developed related evidence using Grade method. Finally the GDG developed the recommendations and suggestions of the guideline.</p><p><strong>Results: </strong>The first three questions in the guideline focus on providing recommendations for handling a patient who experience chest pain at home, in a health house or center, during ambulance transportation, and upon arrival at the emergency department (ED) as well as the initial diagnostic measures in the ED. Subsequently, the recommendations related to the criteria for categorizing patients into low, intermediate and high-risk groups are presented. The guideline addressed primary treatment measures for ACS patients in hospitals with and without code 247 or having primary percutaneous coronary intervention (PCI) facilities, and the appropriate timing for PCI based on the risk assessment. In addition, the most efficacious antiplatelet medications for ACS patients in the ED as well as its optimal duration of treatment are presented. The guideline details the recommendations for therapeutic interventions in patients with ACS and acute heart failure, cardiogenic shock, myocardial infarction with nonobstructive coronary arteries (MINOCA), multivessel occlusion, as well as the indication for prescribing a combined use of anticoagulants and antiplatelet during hospitalization and upon discharge. Regarding secondary prevention, while emphasizing the referral of these patients to rehabilitation centers, other interventions that include pharmaceutical and nonpharmacological ones are addressed, In addition, necessary recommendations for enhancing lifestyle and posthospital discharge pharmaceutical treatments, including their duration, are provided. There are specific recommendations and suggestions for subgroups, such as patients aged over 75 years and individuals with heart failure, diabetes, and chronic kidney disease.</p><p><strong>Conclusion: </strong>Developing guidelines for ACS diagnosis, treatment and secondary prevention according to the local context in Iran can improve the adherence of our health care providers, patients health, and policy makers plans.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"32"},"PeriodicalIF":1.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased rate of skin and soft-tissue infections after chickenpox: Is it related to the COVID-19 pandemic? 水痘后皮肤和软组织感染率增加:是否与 COVID-19 大流行有关?
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_516_23
Shirin Sayyahfar
{"title":"Increased rate of skin and soft-tissue infections after chickenpox: Is it related to the COVID-19 pandemic?","authors":"Shirin Sayyahfar","doi":"10.4103/jrms.jrms_516_23","DOIUrl":"10.4103/jrms.jrms_516_23","url":null,"abstract":"","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"24"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of single absorbable tacker vs. conventional method in fixating the mesh in bilateral inguinal hernia undergoing laparoscopic transabdominal preperitoneal (TAPP): A randomized control trial study. 腹腔镜经腹腹膜前(TAPP)术中固定双侧腹股沟疝网片的单个可吸收夹钳与传统方法的比较:随机对照试验研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_161_23
Pouya Mir Mohammad Sadeghi, Amir Hosein Naseri, Azita Shishegar, Hamid Melali, Ali Ashjaei

Background: The current study aims to investigate the superior mesh fixation method, single absorbable tacker versus conventional method, in patients undergoing bilateral inguinal hernia repair through the laparoscopic total abdominal preperitoneal (TAPP) approach.

Materials and methods: The current randomized clinical trial has been conducted on 81 patients undergoing bilateral hernia repair through TAPP. The patients were randomly assigned into one of the mesh fixation groups including single absorbable tacker (Group S) (n = 41) and conventional method (Group C) (n = 40). All patients were assessed during the hospital stay and 1 month postoperatively to assess the surgery-associated complications and days for return to daily activity. Eura-Hs questionnaire was applied to assess the quality of life (QOL) after hernia surgery during 12-month follow-up.

Results: The duration of bilateral inguinal hernia operation (P = 0.067), postoperative urinary catheterization (P = 0.813), and hospital stay duration (P = 0.779) did not differ between the groups; whereas Group C significantly required a longer time for returning to daily activity (P < 0.001). Only a patient in Group C represented hematoma (P = 0.494). Seroma incidence was not statistically different between the two groups (P = 0.712). Postoperative pain was statistically less in Group S (P < 0.001 for all the assessments). Postoperative QOL within a year after hernia repair revealed an insignificant difference between the groups in general (P > 0.05); however, a pain subscale was significantly less in Group S (P = 0.002).

Conclusion: Based on the findings of this study, a single absorbable tacker was generally superior to the conventional method considering its less pre- and postoperative complications. However, the two methods did not differ regarding 1-year follow-up QOL.

研究背景本研究旨在探讨在通过腹腔镜全腹膜前(TAPP)方法进行双侧腹股沟疝修补术的患者中,单个可吸收粘扣带与传统方法相比更优越的网片固定方法:本随机临床试验针对 81 名通过 TAPP 进行双侧疝修补术的患者。患者被随机分配到网片固定组(S 组)(41 人)和传统方法组(C 组)(40 人)。所有患者均在住院期间和术后 1 个月接受评估,以评估手术相关并发症和恢复日常活动的天数。在12个月的随访中,采用Eura-Hs问卷评估疝气术后的生活质量(QOL):结果:两组患者的双侧腹股沟疝手术时间(P = 0.067)、术后导尿时间(P = 0.813)和住院时间(P = 0.779)均无差异;而 C 组患者恢复日常活动所需的时间明显更长(P < 0.001)。C 组仅有一名患者出现血肿(P = 0.494)。两组血清肿发生率无统计学差异(P = 0.712)。据统计,S 组术后疼痛较轻(所有评估结果的 P 均小于 0.001)。疝修补术后一年内的术后 QOL 显示,两组之间的总体差异不显著(P > 0.05);但是,S 组的疼痛分量表明显较少(P = 0.002):根据本研究的结果,考虑到术前和术后并发症较少,单个可吸收粘贴器总体上优于传统方法。然而,两种方法在一年的随访 QOL 方面并无差异。
{"title":"Comparison of single absorbable tacker vs. conventional method in fixating the mesh in bilateral inguinal hernia undergoing laparoscopic transabdominal preperitoneal (TAPP): A randomized control trial study.","authors":"Pouya Mir Mohammad Sadeghi, Amir Hosein Naseri, Azita Shishegar, Hamid Melali, Ali Ashjaei","doi":"10.4103/jrms.jrms_161_23","DOIUrl":"10.4103/jrms.jrms_161_23","url":null,"abstract":"<p><strong>Background: </strong>The current study aims to investigate the superior mesh fixation method, single absorbable tacker versus conventional method, in patients undergoing bilateral inguinal hernia repair through the laparoscopic total abdominal preperitoneal (TAPP) approach.</p><p><strong>Materials and methods: </strong>The current randomized clinical trial has been conducted on 81 patients undergoing bilateral hernia repair through TAPP. The patients were randomly assigned into one of the mesh fixation groups including single absorbable tacker (Group S) (<i>n</i> = 41) and conventional method (Group C) (<i>n</i> = 40). All patients were assessed during the hospital stay and 1 month postoperatively to assess the surgery-associated complications and days for return to daily activity. Eura-Hs questionnaire was applied to assess the quality of life (QOL) after hernia surgery during 12-month follow-up.</p><p><strong>Results: </strong>The duration of bilateral inguinal hernia operation (<i>P</i> = 0.067), postoperative urinary catheterization (<i>P</i> = 0.813), and hospital stay duration (<i>P</i> = 0.779) did not differ between the groups; whereas Group C significantly required a longer time for returning to daily activity (<i>P</i> < 0.001). Only a patient in Group C represented hematoma (<i>P</i> = 0.494). Seroma incidence was not statistically different between the two groups (<i>P</i> = 0.712). Postoperative pain was statistically less in Group S (<i>P</i> < 0.001 for all the assessments). Postoperative QOL within a year after hernia repair revealed an insignificant difference between the groups in general (<i>P</i> > 0.05); however, a pain subscale was significantly less in Group S (<i>P</i> = 0.002).</p><p><strong>Conclusion: </strong>Based on the findings of this study, a single absorbable tacker was generally superior to the conventional method considering its less pre- and postoperative complications. However, the two methods did not differ regarding 1-year follow-up QOL.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"25"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of fragmented QRS and predictors of outcome in ST-elevation myocardial infarction. ST段抬高型心肌梗死中QRS片段的意义和预后因素
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_68_23
Serdar Türkmen, Mehmet Bozkurt, Yusuf Hoşoğlu, Mehmet Göl

Background: Fragmented QRS (fQRS) might be associated with certain characteristics in ST-elevation myocardial infarction (STEMI) patients and inhospital adverse events.

Materials and methods: A sum of 500 patients were gone over retrospectively. Patients with STEMI, all undergone percutaneous coronary intervention, were grouped as fQRS (-) and fQRS (+). Characteristics of the patients, major adverse cardiac event (MACE), death in hospital, nonfatal myocardial infarction (MI), stent thrombosis, slow flow myocardial perfusion, development of ventricular tachycardia (VT) and fibrillation, cardiogenic shock and cardiopulmonary arrest were filtered.

Results: FQRS (-) group was composed of 207 patients whose mean age was 61.1 ± 12.1, whereas 293 patients were there in fQRS (+) with a mean age of 66.7 ± 10.6 (P < 0.001). Thrombolysis in MI (TIMI) (P < 0.01), the global registry of acute coronary events (GRACE) (P < 0.01) scores, white blood cell count, neutrophil/lymphocyte ratio, MACE and the ratio of death in hospital and VT in the hospital were significantly higher in fQRS (+) group (P < 0.001, for remaining all). In multivariate logistic regression analysis, TIMI scores above 2 and GRACE scores above 109 were determined as independent predictors of MACE in the entire patient group (odds ratio [OR]: 2.022; 95% confidence interval [CI]; 1.321-3.424, P = 0.003; OR: 1.712; 95% CI: 1.156-2.804, P = 0.008).

Conclusion: FQRS (+) and fQRS (-) patients markedly differ from each other in terms of certain demographic and clinical features and TIMI and GRACE scores have a significant predictive value for MACE in all STEMI patients' group.

背景:片段QRS(fQRS)可能与ST段抬高型心肌梗死(STEMI)患者的某些特征和院内不良事件有关:对500例患者进行回顾性研究。所有接受经皮冠状动脉介入治疗的 STEMI 患者被分为 fQRS(-)和 fQRS(+)两组。对患者的特征、主要心脏不良事件(MACE)、住院死亡、非致死性心肌梗死(MI)、支架血栓、慢流心肌灌注、室速(VT)和室颤、心源性休克和心肺骤停进行筛选:FQRS(-)组有 207 名患者,平均年龄为(61.1 ± 12.1)岁,而 FQRS(+)组有 293 名患者,平均年龄为(66.7 ± 10.6)岁(P < 0.001)。fQRS(+)组患者的心肌梗死溶栓治疗(TIMI)(P<0.01)、急性冠状动脉事件全球登记(GRACE)(P<0.01)评分、白细胞计数、中性粒细胞/淋巴细胞比值、MACE以及住院死亡和VT的比例均显著高于fQRS(+)组(其余均为P<0.001)。在多变量逻辑回归分析中,TIMI评分超过2分和GRACE评分超过109分被确定为整个患者组MACE的独立预测因素(几率比[OR]:2.022;95%置信区间[CI]:1.321-3.424,P = 0.003;OR:1.712;95% CI:1.156-2.804,P = 0.008):结论:FQRS(+)和fQRS(-)患者在某些人口统计学和临床特征方面存在明显差异,TIMI和GRACE评分对所有STEMI患者组的MACE具有显著的预测价值。
{"title":"Significance of fragmented QRS and predictors of outcome in ST-elevation myocardial infarction.","authors":"Serdar Türkmen, Mehmet Bozkurt, Yusuf Hoşoğlu, Mehmet Göl","doi":"10.4103/jrms.jrms_68_23","DOIUrl":"10.4103/jrms.jrms_68_23","url":null,"abstract":"<p><strong>Background: </strong>Fragmented QRS (fQRS) might be associated with certain characteristics in ST-elevation myocardial infarction (STEMI) patients and inhospital adverse events.</p><p><strong>Materials and methods: </strong>A sum of 500 patients were gone over retrospectively. Patients with STEMI, all undergone percutaneous coronary intervention, were grouped as fQRS (-) and fQRS (+). Characteristics of the patients, major adverse cardiac event (MACE), death in hospital, nonfatal myocardial infarction (MI), stent thrombosis, slow flow myocardial perfusion, development of ventricular tachycardia (VT) and fibrillation, cardiogenic shock and cardiopulmonary arrest were filtered.</p><p><strong>Results: </strong>FQRS (-) group was composed of 207 patients whose mean age was 61.1 ± 12.1, whereas 293 patients were there in fQRS (+) with a mean age of 66.7 ± 10.6 (<i>P</i> < 0.001). Thrombolysis in MI (TIMI) (<i>P</i> < 0.01), the global registry of acute coronary events (GRACE) (<i>P</i> < 0.01) scores, white blood cell count, neutrophil/lymphocyte ratio, MACE and the ratio of death in hospital and VT in the hospital were significantly higher in fQRS (+) group (<i>P</i> < 0.001, for remaining all). In multivariate logistic regression analysis, TIMI scores above 2 and GRACE scores above 109 were determined as independent predictors of MACE in the entire patient group (odds ratio [OR]: 2.022; 95% confidence interval [CI]; 1.321-3.424<i>, P</i> = 0.003; OR: 1.712; 95% CI: 1.156-2.804<i>, P</i> = 0.008).</p><p><strong>Conclusion: </strong>FQRS (+) and fQRS (-) patients markedly differ from each other in terms of certain demographic and clinical features and TIMI and GRACE scores have a significant predictive value for MACE in all STEMI patients' group.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"23"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evaluation of human endogenous retroviral env expression in normal and cancerous tissues of the breast. 评估正常和癌变乳腺组织中人类内源性逆转录病毒 env 的表达。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_141_23
Shaian Tavakolian, Hossein Goudarzi, Ebrahim Faghihloo

Background: Both internal and external risk factors can accelerate the progression of breast cancer which is the reason why clinicians have tried to find new biomarkers for this health problem. Human endogenous retrovirus-W (HERV-W) can be one of these biomarkers, as it has been mentioned that some genes of this virus are able to have either higher or lower expression in numerous cancerous cells. In this study, we aimed to compare HERV-W envelope expression in breast cancer tissues and normal ones since its effects on this malignancy have not been clear.

Materials and methods: We collected 46 breast cancer tissues and their normal adjacent ones. After extracting the RNA of breast samples, we evaluated the expression of HERV-W envelope syncytin-1 and 2 using quantitative real-time polymerase chain reaction (PCR) in different kinds of breast cancer stages.

Results: Data showed that more than 13% of patients had a family history of breast cancer; moreover, approximately half of the tissues were estrogen receptor or progesterone receptor positive. Lymph node metastasis was seen in 52% of the patients, and about 40% of tumors were larger than 2 cm. Real-time PCR showed that syncytin-1 and 2 had upward regulation with (*P < 0.05) and (**P < 0.01), respectively.

Conclusion: As the expression of HERV-W Env (syncytin-1, syncytin-2) was higher in breast cancerous tissues in comparison with normal ones, we believe that these genes may have a role to play in monitoring patients suffering from this type of cancer. However, further studies are needed to confirm this hypothesis.

背景:内部和外部风险因素都会加速乳腺癌的发展,这也是临床医生试图为这一健康问题寻找新生物标志物的原因。人类内源性逆转录病毒-W(HERV-W)可以作为这些生物标志物之一,因为有研究指出,这种病毒的某些基因在许多癌细胞中都有或高或低的表达。在本研究中,我们旨在比较 HERV-W 包膜在乳腺癌组织和正常组织中的表达情况,因为 HERV-W 对这种恶性肿瘤的影响尚未明确:我们收集了 46 例乳腺癌组织及其邻近的正常组织。材料:我们收集了 46 例乳腺癌组织及其邻近的正常组织,提取乳腺样本的 RNA 后,使用实时定量聚合酶链反应(PCR)评估 HERV-W 包膜 syncytin-1 和 2 在不同分期乳腺癌中的表达情况:数据显示,超过 13% 的患者有乳腺癌家族史;此外,约半数组织的雌激素受体或孕激素受体呈阳性。52%的患者出现淋巴结转移,约40%的肿瘤大于2厘米。实时 PCR 显示,syncytin-1 和 2 具有向上调节作用,分别为(*P < 0.05)和(**P < 0.01):由于 HERV-W Env(syncytin-1、syncytin-2)在乳腺癌组织中的表达高于正常组织,我们认为这些基因可能在监测乳腺癌患者方面发挥作用。不过,要证实这一假设,还需要进一步的研究。
{"title":"The evaluation of human endogenous retroviral env expression in normal and cancerous tissues of the breast.","authors":"Shaian Tavakolian, Hossein Goudarzi, Ebrahim Faghihloo","doi":"10.4103/jrms.jrms_141_23","DOIUrl":"10.4103/jrms.jrms_141_23","url":null,"abstract":"<p><strong>Background: </strong>Both internal and external risk factors can accelerate the progression of breast cancer which is the reason why clinicians have tried to find new biomarkers for this health problem. Human endogenous retrovirus-W (HERV-W) can be one of these biomarkers, as it has been mentioned that some genes of this virus are able to have either higher or lower expression in numerous cancerous cells. In this study, we aimed to compare HERV-W envelope expression in breast cancer tissues and normal ones since its effects on this malignancy have not been clear.</p><p><strong>Materials and methods: </strong>We collected 46 breast cancer tissues and their normal adjacent ones. After extracting the RNA of breast samples, we evaluated the expression of HERV-W envelope syncytin-1 and 2 using quantitative real-time polymerase chain reaction (PCR) in different kinds of breast cancer stages.</p><p><strong>Results: </strong>Data showed that more than 13% of patients had a family history of breast cancer; moreover, approximately half of the tissues were estrogen receptor or progesterone receptor positive. Lymph node metastasis was seen in 52% of the patients, and about 40% of tumors were larger than 2 cm. Real-time PCR showed that syncytin-1 and 2 had upward regulation with (*<i>P</i> < 0.05) and (**<i>P</i> < 0.01), respectively.</p><p><strong>Conclusion: </strong>As the expression of HERV-W Env (syncytin-1, syncytin-2) was higher in breast cancerous tissues in comparison with normal ones, we believe that these genes may have a role to play in monitoring patients suffering from this type of cancer. However, further studies are needed to confirm this hypothesis.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"20"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of recurrence of joint symptoms after COVID-19 in patients with rheumatoid arthritis: Cross-sectional study. 类风湿性关节炎患者服用 COVID-19 后关节症状复发的调查:横断面研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_782_22
Afsaneh Akbarpour, Mansour Salesi, Anahita Babak

Background: In this study, the relationship between involvement by COVID-19 and the recurrence of symptoms of rheumatoid arthritis (RA) was investigated.

Materials and methods: This cross-sectional study was conducted on 112 patients with RA with and without a history of COVID-19. The severity and recurrence of RA symptoms were measured and recorded by the Disease Activity Score in 28 joints (DAS-28) index and clinical evaluations by a rheumatologist.

Results: The results showed that the recurrence of RA in patients with and without a history of COVID-19 had a statistically significant difference (P < 0.001). In addition, there was a statistically significant relationship between erythrocyte sedimentation rate, visual analogue scale (VAS), tender joint count, swollen joint count, and DAS-28 and the history of COVID-19 (P < 0.05).

Conclusion: The present study showed that infection with COVID-19 leads to the recurrence of joint symptoms in RA patients.

背景:本研究调查了COVID-19受累与类风湿关节炎(RA)症状复发之间的关系:这项横断面研究的对象是112名有COVID-19病史和无COVID-19病史的RA患者。通过 28 个关节的疾病活动度评分(DAS-28)指数和风湿免疫科医生的临床评估来测量和记录 RA 症状的严重程度和复发情况:结果显示,有COVID-19病史和无COVID-19病史的患者的RA复发率有显著统计学差异(P<0.001)。此外,红细胞沉降率、视觉模拟量表(VAS)、关节触痛计数、关节肿胀计数和DAS-28与COVID-19病史之间存在统计学意义上的显著关系(P<0.05):本研究表明,感染 COVID-19 会导致 RA 患者关节症状复发。
{"title":"Investigation of recurrence of joint symptoms after COVID-19 in patients with rheumatoid arthritis: Cross-sectional study.","authors":"Afsaneh Akbarpour, Mansour Salesi, Anahita Babak","doi":"10.4103/jrms.jrms_782_22","DOIUrl":"10.4103/jrms.jrms_782_22","url":null,"abstract":"<p><strong>Background: </strong>In this study, the relationship between involvement by COVID-19 and the recurrence of symptoms of rheumatoid arthritis (RA) was investigated.</p><p><strong>Materials and methods: </strong>This cross-sectional study was conducted on 112 patients with RA with and without a history of COVID-19. The severity and recurrence of RA symptoms were measured and recorded by the Disease Activity Score in 28 joints (DAS-28) index and clinical evaluations by a rheumatologist.</p><p><strong>Results: </strong>The results showed that the recurrence of RA in patients with and without a history of COVID-19 had a statistically significant difference (<i>P</i> < 0.001). In addition, there was a statistically significant relationship between erythrocyte sedimentation rate, visual analogue scale (VAS), tender joint count, swollen joint count, and DAS-28 and the history of COVID-19 (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The present study showed that infection with COVID-19 leads to the recurrence of joint symptoms in RA patients.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"21"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The connection between hypertension and diabetes and their role in heart and kidney disease development. 高血压和糖尿病之间的联系及其在心脏和肾脏疾病发展中的作用。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-29 eCollection Date: 2024-01-01 DOI: 10.4103/jrms.jrms_470_23
Ali Ahmed Mohammed Hezam, Hanan Basheer Mohammed Shaghdar, Liying Chen

Hypertension and diabetes are two common metabolic disorders that often coexist in the same individual. Their concurrence increases the risk of cardiovascular disease, renal dysfunction, and other complications. Cardiovascular disease is the primary cause of morbidity and mortality in individuals with diabetes, and hypertension further aggravates this condition. Interestingly, hypertension and diabetes share several common pathophysiological mechanisms including insulin resistance, vascular inflammation, endothelial dysfunction, obesity, and oxidative stress suggesting a cross-talk between these two conditions that could potentially contribute to the development of other human diseases. Effective management of diabetes should include a multifaceted approach that addresses not only glycemic control but also blood pressure (BP) and lipid control. Treatment plans should be individualized to each patient's needs and should involve a combination of lifestyle modifications and medications to achieve optimal control. With the availability of newer antidiabetic medications such as SGLT inhibitors and GLP1 receptor agonists, it is crucial to consider their potential to reduce BP, enhance kidney function, and lower the risk of cardiovascular diseases when initiating treatment for glycemic control. A more profound comprehension of the shared underlying mechanisms between these conditions could pave the way for the development of innovative therapeutic approaches to tackle them. Our review offers an in-depth analysis of the literature, providing a holistic view of the mechanisms underlying diabetes-hypertension comorbidity and its implications on heart and kidney diseases. The present article concludes by discussing current approaches for managing hypertensive diabetic patients to create a set of comprehensive individualized recommendations.

高血压和糖尿病是两种常见的代谢性疾病,经常在同一个人身上同时存在。它们的同时存在会增加心血管疾病、肾功能障碍和其他并发症的风险。心血管疾病是糖尿病患者发病和死亡的主要原因,而高血压则会进一步加重病情。有趣的是,高血压和糖尿病有几种共同的病理生理机制,包括胰岛素抵抗、血管炎症、内皮功能障碍、肥胖和氧化应激,这表明这两种疾病之间存在相互影响,有可能导致其他人类疾病的发生。糖尿病的有效治疗应包括多方面的方法,不仅要控制血糖,还要控制血压和血脂。治疗方案应根据每位患者的需求进行个性化设计,并应将改变生活方式和药物治疗相结合,以达到最佳控制效果。随着 SGLT 抑制剂和 GLP1 受体激动剂等新型抗糖尿病药物的出现,在开始血糖控制治疗时,必须考虑这些药物降低血压、增强肾功能和降低心血管疾病风险的潜力。更深入地了解这些病症之间的共同内在机制可为开发创新的治疗方法铺平道路。我们的综述对文献进行了深入分析,提供了糖尿病与高血压并发症的内在机制及其对心脏和肾脏疾病影响的整体观点。最后,本文讨论了目前管理高血压糖尿病患者的方法,以制定一套全面的个性化建议。
{"title":"The connection between hypertension and diabetes and their role in heart and kidney disease development.","authors":"Ali Ahmed Mohammed Hezam, Hanan Basheer Mohammed Shaghdar, Liying Chen","doi":"10.4103/jrms.jrms_470_23","DOIUrl":"10.4103/jrms.jrms_470_23","url":null,"abstract":"<p><p>Hypertension and diabetes are two common metabolic disorders that often coexist in the same individual. Their concurrence increases the risk of cardiovascular disease, renal dysfunction, and other complications. Cardiovascular disease is the primary cause of morbidity and mortality in individuals with diabetes, and hypertension further aggravates this condition. Interestingly, hypertension and diabetes share several common pathophysiological mechanisms including insulin resistance, vascular inflammation, endothelial dysfunction, obesity, and oxidative stress suggesting a cross-talk between these two conditions that could potentially contribute to the development of other human diseases. Effective management of diabetes should include a multifaceted approach that addresses not only glycemic control but also blood pressure (BP) and lipid control. Treatment plans should be individualized to each patient's needs and should involve a combination of lifestyle modifications and medications to achieve optimal control. With the availability of newer antidiabetic medications such as SGLT inhibitors and GLP1 receptor agonists, it is crucial to consider their potential to reduce BP, enhance kidney function, and lower the risk of cardiovascular diseases when initiating treatment for glycemic control. A more profound comprehension of the shared underlying mechanisms between these conditions could pave the way for the development of innovative therapeutic approaches to tackle them. Our review offers an in-depth analysis of the literature, providing a holistic view of the mechanisms underlying diabetes-hypertension comorbidity and its implications on heart and kidney diseases. The present article concludes by discussing current approaches for managing hypertensive diabetic patients to create a set of comprehensive individualized recommendations.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"29 ","pages":"22"},"PeriodicalIF":1.6,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How much natural ventilation rate can suppress COVID-19 transmission in occupancy zones? 多少自然通风率可以抑制 COVID-19 在居住区的传播?
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-02-23 eCollection Date: 2023-01-01 DOI: 10.4103/jrms.jrms_796_22
Amir Nejatian, Faranak Ebrahimian Sadabad, Farshad M Shirazi, Seyed Faraz Nejati, Samaneh Nakhaee, Omid Mehrpour

Background: Previous research has emphasized the importance of efficient ventilation in suppressing COVID-19 transmission in indoor spaces, yet suitable ventilation rates have not been suggested.

Materials and methods: This study investigated the impacts of mechanical, natural, single-sided, cross-ventilation, and three mask types (homemade, surgical, N95) on COVID-19 spread across eight common indoor settings. Viral exposure was quantified using a mass balance calculation of inhaled viral particles, accounting for initial viral load, removal via ventilation, and mask filtration efficiency.

Results: Results demonstrated that natural cross-ventilation significantly reduced viral load, decreasing from 10,000 to 0 viruses over 15 minutes in a 100 m2 space by providing ~1325 m3/h of outdoor air via two 0.6 m2 openings at 1.5 m/s wind speed. In contrast, single-sided ventilation only halved viral load at best.

Conclusion: Natural cross-ventilation with masks effectively suppressed airborne viruses, lowering potential infections and disease transmission. The study recommends suitable ventilation rates to reduce COVID-19 infection risks in indoor spaces.

背景:以往的研究强调了有效通风对抑制 COVID-19 在室内空间传播的重要性,但尚未提出合适的通风率:本研究调查了机械通风、自然通风、单侧通风、交叉通风以及三种口罩类型(自制口罩、外科口罩、N95口罩)对八种常见室内环境中 COVID-19 传播的影响。使用吸入病毒颗粒的质量平衡计算方法对病毒暴露进行量化,同时考虑初始病毒载量、通风清除量和口罩过滤效率:结果表明,在风速为 1.5 米/秒的条件下,通过两个 0.6 平方米的开口,每小时可提供约 1325 立方米的室外空气,自然交叉通风可显著降低病毒载量,在 100 平方米的空间内,15 分钟内病毒载量从 10,000 个降至 0 个。相比之下,单侧通风最多只能将病毒量减半:结论:戴口罩的自然交叉通风可有效抑制空气中的病毒,降低潜在的感染和疾病传播。研究建议采用合适的通风率来降低 COVID-19 在室内空间的感染风险。
{"title":"How much natural ventilation rate can suppress COVID-19 transmission in occupancy zones?","authors":"Amir Nejatian, Faranak Ebrahimian Sadabad, Farshad M Shirazi, Seyed Faraz Nejati, Samaneh Nakhaee, Omid Mehrpour","doi":"10.4103/jrms.jrms_796_22","DOIUrl":"10.4103/jrms.jrms_796_22","url":null,"abstract":"<p><strong>Background: </strong>Previous research has emphasized the importance of efficient ventilation in suppressing COVID-19 transmission in indoor spaces, yet suitable ventilation rates have not been suggested.</p><p><strong>Materials and methods: </strong>This study investigated the impacts of mechanical, natural, single-sided, cross-ventilation, and three mask types (homemade, surgical, N95) on COVID-19 spread across eight common indoor settings. Viral exposure was quantified using a mass balance calculation of inhaled viral particles, accounting for initial viral load, removal via ventilation, and mask filtration efficiency.</p><p><strong>Results: </strong>Results demonstrated that natural cross-ventilation significantly reduced viral load, decreasing from 10,000 to 0 viruses over 15 minutes in a 100 m2 space by providing ~1325 m3/h of outdoor air via two 0.6 m2 openings at 1.5 m/s wind speed. In contrast, single-sided ventilation only halved viral load at best.</p><p><strong>Conclusion: </strong>Natural cross-ventilation with masks effectively suppressed airborne viruses, lowering potential infections and disease transmission. The study recommends suitable ventilation rates to reduce COVID-19 infection risks in indoor spaces.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"84"},"PeriodicalIF":1.6,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of oral zinc on hemoglobin and dose of erythropoietin in hemodialysis patients. 口服锌对血液透析患者血红蛋白和促红细胞生成素剂量的影响。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-02-23 eCollection Date: 2023-01-01 DOI: 10.4103/jrms.jrms_271_23
Shiva Seirafian, Awat Feizi, Shahrzad Shahidi, Shirin Sadat Badri, Mohammad Hossein Rouhani, Pejman Pourazari Najafabadi, Elham Kabiri Naeini

Background: In hemodialysis (HD) patients, low serum zinc level could cause hyporesponsivity to erythropoiesis-stimulating agents and lead to anemia. This study investigated the effects of oral zinc supplements on the required dose of erythropoietin in patients undergoing HD.

Materials and methods: In a double-blinded randomized trial, 76 HD patients were assigned to 2 groups of 38. One group (intervention) was treated with oral zinc supplements of 210 mg, daily for 6 months, and the other group (control) used placebo capsules for 6 months. The serum zinc level, hemoglobin level, and required dose of erythropoietin, albumin, ferritin, ferrous, and total iron-binding capacity were evaluated 3 and 6 months after intervention.

Results: Repeated measures ANOVA did not show a significant increase in Hb level after 6 months of intervention (P = 0.28). However, the required dose of erythropoietin was decreased, but the changes were not statistically significant (P > 0.05). The changes in the other variables were not statistically significant.

Conclusion: Oral zinc supplementation in HD patients could not increase hemoglobin level irrespective of their serum zinc level.

背景:在血液透析(HD)患者中,血清锌水平低会导致对促红细胞生成药物的反应迟钝,从而导致贫血。本研究调查了口服锌补充剂对血液透析患者所需红细胞生成素剂量的影响:在一项双盲随机试验中,76 名血液透析患者被分为两组,每组 38 人。一组(干预组)每天口服 210 毫克锌补充剂,持续 6 个月;另一组(对照组)服用安慰剂胶囊,持续 6 个月。干预3个月和6个月后,对血清锌水平、血红蛋白水平、促红细胞生成素所需剂量、白蛋白、铁蛋白、亚铁和总铁结合能力进行评估:结果:重复测量方差分析显示,干预 6 个月后,血红蛋白水平没有显著提高(P = 0.28)。不过,所需的促红细胞生成素剂量有所减少,但变化无统计学意义(P > 0.05)。其他变量的变化无统计学意义:结论:无论血清锌水平如何,口服锌补充剂都无法提高 HD 患者的血红蛋白水平。
{"title":"The effect of oral zinc on hemoglobin and dose of erythropoietin in hemodialysis patients.","authors":"Shiva Seirafian, Awat Feizi, Shahrzad Shahidi, Shirin Sadat Badri, Mohammad Hossein Rouhani, Pejman Pourazari Najafabadi, Elham Kabiri Naeini","doi":"10.4103/jrms.jrms_271_23","DOIUrl":"10.4103/jrms.jrms_271_23","url":null,"abstract":"<p><strong>Background: </strong>In hemodialysis (HD) patients, low serum zinc level could cause hyporesponsivity to erythropoiesis-stimulating agents and lead to anemia. This study investigated the effects of oral zinc supplements on the required dose of erythropoietin in patients undergoing HD.</p><p><strong>Materials and methods: </strong>In a double-blinded randomized trial, 76 HD patients were assigned to 2 groups of 38. One group (intervention) was treated with oral zinc supplements of 210 mg, daily for 6 months, and the other group (control) used placebo capsules for 6 months. The serum zinc level, hemoglobin level, and required dose of erythropoietin, albumin, ferritin, ferrous, and total iron-binding capacity were evaluated 3 and 6 months after intervention.</p><p><strong>Results: </strong>Repeated measures ANOVA did not show a significant increase in Hb level after 6 months of intervention (<i>P</i> = 0.28). However, the required dose of erythropoietin was decreased, but the changes were not statistically significant (<i>P</i> > 0.05). The changes in the other variables were not statistically significant.</p><p><strong>Conclusion: </strong>Oral zinc supplementation in HD patients could not increase hemoglobin level irrespective of their serum zinc level.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"85"},"PeriodicalIF":1.6,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1